Sight Sciences (SGHT) Change in Account Payables (2020 - 2026)
Sight Sciences (SGHT) recorded quarterly Change in Account Payables of $143000.0 in Q1 2026, up 135.93% quarter-over-quarter from -$398000.0 in Q4 2025, and down 86.67% on a YoY basis from $1.1 million in Q1 2025.
Sight Sciences (SGHT) Change in Account Payables (2020 - 2026) Analysis & Trends
Sight Sciences' Change in Account Payables history runs 7 years deep, the most recent figure standing at $143000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 86.67% year-over-year to $143000.0; the TTM figure through Mar 2026 stood at -$1.3 million (down 223.12% YoY), while the FY2025 annual figure was -$348000.0, down 203.57% from the prior year.
- Change in Account Payables was $143000.0 for Q1 2026 at Sight Sciences, up from -$398000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q1 2025 to a low of -$1.7 million in Q4 2023.
- Historically, Change in Account Payables has averaged -$85058.8 across 5 years, with a median of -$248000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Change in Account Payables surged 454.03% in 2023, then slumped 368.75% in 2025.
- A 5-year view of Change in Account Payables shows it stood at -$617000.0 in 2022, then tumbled by 179.42% to -$1.7 million in 2023, then soared by 121.87% to $377000.0 in 2024, then tumbled by 205.57% to -$398000.0 in 2025, then soared by 135.93% to $143000.0 in 2026.
- The last three Change in Account Payables figures came in at $143000.0 (Q1 2026), -$398000.0 (Q4 2025), and -$335000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Sight Sciences | 284.28 Mn | 199.32 Mn | 16.98 Mn | 143,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 143,000.00 |
| Mar 31, 2026 | 143,000.00 |
| Dec 31, 2025 | -398,000.00 |
| Dec 31, 2025 | -398,000.00 |
| Sep 30, 2025 | -335,000.00 |
| Sep 30, 2025 | -335,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Jun 30, 2025 | -688,000.00 |
| Mar 31, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 377,000.00 |
| Dec 31, 2024 | 377,000.00 |
| Sep 30, 2024 | -668,000.00 |
| Sep 30, 2024 | -668,000.00 |
| Jun 30, 2024 | 256,000.00 |
| Jun 30, 2024 | 256,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Dec 31, 2023 | -1.72 Mn |
| Dec 31, 2023 | -1.72 Mn |